Does FILGRASTIM Cause Malignant neoplasm progression? 157 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 157 reports of Malignant neoplasm progression have been filed in association with FILGRASTIM (NYPOZI txid). This represents 1.1% of all adverse event reports for FILGRASTIM.
157
Reports of Malignant neoplasm progression with FILGRASTIM
1.1%
of all FILGRASTIM reports
63
Deaths
40
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FILGRASTIM?
Of the 157 reports, 63 (40.1%) resulted in death, 40 (25.5%) required hospitalization, and 14 (8.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM. However, 157 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM Cause?
Off label use (1,930)
Febrile neutropenia (1,570)
Neutropenia (1,431)
Death (1,213)
Pyrexia (1,085)
Diarrhoea (739)
Nausea (718)
Bone pain (706)
Thrombocytopenia (697)
Anaemia (626)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which FILGRASTIM Alternatives Have Lower Malignant neoplasm progression Risk?
FILGRASTIM vs FILGRASTIM-AAFI
FILGRASTIM vs FILGRASTIM-SNDZ
FILGRASTIM vs FINASTERIDE
FILGRASTIM vs FINASTERIDE\TAMSULOSIN
FILGRASTIM vs FINERENONE